rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
2002-12-5
|
pubmed:abstractText |
Transcoronary ethanol septal ablation (TESA) is a novel treatment for obstructive hypertrophic cardiomyopathy (HOCM). Our objective was to evaluate the use of gated single photon emission computed tomography (SPECT) in patients with HOCM and the effects of TESA on myocardial perfusion.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1071-3581
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
9
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
594-600
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:12466783-Adolescent,
pubmed-meshheading:12466783-Adult,
pubmed-meshheading:12466783-Aged,
pubmed-meshheading:12466783-Aged, 80 and over,
pubmed-meshheading:12466783-Cardiomyopathy, Hypertrophic,
pubmed-meshheading:12466783-Cohort Studies,
pubmed-meshheading:12466783-Drug Delivery Systems,
pubmed-meshheading:12466783-Ethanol,
pubmed-meshheading:12466783-Female,
pubmed-meshheading:12466783-Gated Blood-Pool Imaging,
pubmed-meshheading:12466783-Heart Catheterization,
pubmed-meshheading:12466783-Heart Septum,
pubmed-meshheading:12466783-Humans,
pubmed-meshheading:12466783-Male,
pubmed-meshheading:12466783-Middle Aged,
pubmed-meshheading:12466783-Myocardial Infarction,
pubmed-meshheading:12466783-Reproducibility of Results,
pubmed-meshheading:12466783-Sensitivity and Specificity,
pubmed-meshheading:12466783-Treatment Outcome,
pubmed-meshheading:12466783-Ventricular Dysfunction, Left
|
pubmed:articleTitle |
Gated SPECT in patients with hypertrophic obstructive cardiomyopathy undergoing transcoronary ethanol septal ablation.
|
pubmed:affiliation |
Section of Cardiology, Baylor College of Medicine and The Methodist Hospital, Houston, TX 77030, USA. sherifn@bcm.tmc.edu
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|